A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of the combination of
Pembrolizumab (KEYTRUDA®) and the investigational drug, Metformin.